Biomark Diagnostics Inc. (CSE:BUX)
 0.3400
 -0.0050 (-1.47%)
  Oct 31, 2025, 9:31 AM EDT
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of CAD 32.79 million as of October 31, 2025. Its market cap has increased by 73.14% in one year.
Market Cap 
 32.79M
Enterprise Value 
 31.71M
Revenue 
 154.90K
Ranking 
 n/a
PE Ratio 
 n/a
Stock Price 
0.34
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has decreased from 40.39M to 32.79M, a decrease of -18.80%. That is a compound annual growth rate of -1.89%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 32.79M | 121.70% | 
| Dec 30, 2024 | 14.79M | -17.24% | 
| Dec 29, 2023 | 17.87M | 24.67% | 
| Dec 30, 2022 | 14.34M | -23.96% | 
| Dec 30, 2021 | 18.85M | 116.77% | 
| Dec 30, 2020 | 8.70M | -51.10% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Curaleaf Holdings | 2.98B | 
| Green Thumb Industries | 2.21B | 
| dentalcorp Holdings | 2.17B | 
| Trulieve Cannabis | 1.85B | 
| Sienna Senior Living | 1.77B | 
| Extendicare | 1.33B | 
| WELL Health Technologies | 1.32B | 
| Cronos Group | 1.31B |